Andorra vs Latvia: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Andorra
- Latvia
How they compare
Andorra currently reports 35.5% against 34.6% in Latvia, a difference of 0.9%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Latvia ahead.
Andorra ranks 12th and Latvia ranks 15th of 166 countries.
Across the 3 decades both report, Andorra averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Andorra | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.7% | 42.5% | 6.8% | Latvia |
| 2010s | 35.4% | 38.9% | 3.5% | Latvia |
| 2020s | 35.4% | 35.2% | 0.2% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Andorra or Latvia?
- Andorra, at 35.5% against 34.6% in Latvia as of 2024.
- What is the difference in prevalence of current tobacco use between Andorra and Latvia?
- 0.9%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Latvia?
- 9 years are reported by both, from 2000 to 2024.
- How do Andorra and Latvia rank globally for prevalence of current tobacco use?
- Andorra ranks 12th and Latvia ranks 15th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.